PFE trade ideas
PFizer D1The disease statistics for the Coronavirus in the world has reached the level of 1,000,000 population. This situation creates enormous problems for the economy and for the life of people in general. But for the PFizer company, this just gives a huge potential for the possibility of earning money on this problem. Because the market has a huge potential for sales. And the bulk of people will be vaccinated with this particular vaccine. And this will be government procurement, which will amount to millions of dollars in revenue for the company. Which will stimulate stocks to grow.
Phizer pulling back nicely to support trendlineShares of Phizer (NYSE:PFE) are pulling back nicely to the trendline going back to March of last year. The share is also touching its 200MA. Results are due on Tuesday next week so Im keeping a close eye on this one. If we get a bounce the share could be on its way back to previous highs reached in November 2018, given a potential return of 20% over the coming year. As a bonus, the share is also a good dividend payer. Pfizers contribution to the vaccine and Covid fight should also provide some long term support.
Looks like PFE it's going to break upFrom the technical point of view, if PFE breaks the resistance level noted in this chart it can go easily over 40$ USD after earnings.
There's no reason to short Pfizer right now. The company got massive amount of money from vaccine pre-orders, investments and probably the earnings will be at last at estimated level.
Pfizer forming a double bottom to continue moving up?Another update on PFE. Price has stalled for some time now around the internal support. We have a divergence with RSI and the price and RSI is starting to move above 50. MACD is making a bullish crossing and the histogram is going positive as well. Volumes are showing buying activity and we have a potential setup for a double bottom. Keep an eye on PFE.
Myovant Sciences and Pfizer Announce Positive One-Year Data fromMYOV,PFE: Myovant Sciences, Inc.
2021-01-26 06:55:00
Myovant Sciences and Pfizer Announce Positive One-Year Data from Phase 3 SPIRIT Extension Study of Once-Daily Relugolix Combination Therapy in Women with Endometriosis
PFE elliott wavesVaccine Chickens Coming Home To Roost.
Slow mover at the bottoms but it can run like a Chicken With Its head Cut Off after the next break above 43.
Ex-dividend date - An end to investors' hesitation?Good evening.
Price has remained awfully quiet in anticipation of bad headlines. When those headlines actually arrived (23 elderly patients dead in Norway), they were swept under the rug by media world-wide, or just shrugged off.
Source: Bloomberg - Pfizer Vaccine Safe for Elderly Despite Norway Scare, WHO Says
Price has remained extremely stable around 36.22-37.78$ but the ex-dividend date is 28th of January, which means if investors were looking to buy but were hesitant, they'll have to pull the trigger in the coming 2 days or miss out on the dividends of the quarter. Q4 2020 Earnings report is expected on the 2nd of February.
Might be exactly what PFE needs to break out towards 42.50$ again. Especially considering the company's pledge to make 1.3 to 2 billion doses in 2021.
P.S.: Pfizer is looking at a 50% COVID vaccine earnings split with BioNTech, or even slightly more.
Source: Motley Fool - What Does 2021 Hold for BioNTech Stock?
$PFE Uptrend?Hopefully we can see some upward movement before earnings.
RSI indicates still neutral at 52
MACD shows small buyer volume
STOCH RSI indicates crossover towards bullish
$PFE touched the bottom of the canal$PFE touched the bottom of the canal. Ready to come back to the top. Targets could be $39.8, $41.3 and $44-$46.
Pfizer D (long)Wave (II) is ongoing and will not retrace below averge price 36$ (which is EMA200 at the same time)
Major Seller Exhaustion its got divergences all over the place on every time scale, its at the bottom of a range for 2020. three rising valley bla bla bla. just look at the chart.
Has some turnaround potentialIf 35.20 can hold, I reckon this could test 38 to reset the indicators and start the ramp for ER. Countertrend theory, so test of 38 is key. Otherwise, path of least resistance is down.
PFE Monthly 2021-01-23PFE could have formed a gigantic cup&handle over the course of 21 years.
This can be a solid place to buy PFE for a long term hold.
Also, really not sure if we can apply TA to a timeframe this large, but it's fun to think about.
PFE - EW analysis - ABC cycle down PFE - It is forming flat like B wave, where c of B wave up is in progress. Sell when B wave finished near 39 level for C wave down as expected earlier.
Give thumbs up if you really like the trade idea.
Wait Until The Price Comes Out From The Green BoxPay attention to the Head & Shoulders Patten, if the chart breaks the neck line and then the important support it may decrease until to the head & shoulders target.
Long position for Pfizer Inc?1. Price already at the low of the channel
2. Also aligns with 200DMA
3. BIDEN PROMISED 100 MILLION VACCINATIONS WITHIN 100 DAYS OF OFFICE, other countries will be looking vaccinate too that implies production and thats value for the company
BUY $PFE - NRPicks Ene 17Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. Pfizer mainly sells prescription drugs and vaccines, also spends a leading amount on research and development, close to $8 billion annually.
The company has developed its COVID-19 vaccine, however, it has not reflected its optimism in the stock price. The company has generated the same income quarter by quarter during the year, so we can see a good future for the development of its vaccine and the development of the new strain of the virus.
Fundamentals:
- Value
- P/B 3.1x VS 4.3x Industry
- ROE 22% vs. 17% industry
Technicians:
- Price level below SMA 250-200-150
- Williams R% at -50% levels
- RSI (40) Midlevel
- +1% average upside during the month
As a result of the allergic reactions to the vaccine presented, PFE presented a 15% correction from December 8 to December 31, which stopped at a support of $36.3. From this point on, the stock presented a change in trend, which could continue due to the fact that the stock is below its medium term moving average.
Pfizer INCPfizer and BioNTech made a vaccine from coronavirus and when it will come out for everyone, the price will grow up. It’s nice position for buy⬆️
